Neurogene Inc (NGNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -20,637 | -18,388 | -8,642 | -69,442 | -61,341 |
| Depreciation Amortization | 1,362 | 921 | 699 | 528 | 256 |
| Other Working Capital | 243 | 263 | 834 | -1,954 | -4,426 |
| Other Operating Activity | 3,686 | 1,970 | 669 | 55,474 | 54,753 |
| Operating Cash Flow | $-15,346 | $-15,234 | $-6,440 | $-15,394 | $-10,758 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,566 | -1,079 | -107 | -879 | -97 |
| Net Acquisitions | N/A | N/A | N/A | 191 | 191 |
| Investing Cash Flow | $-1,566 | $-1,079 | $-107 | $-688 | $94 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -49 | -4 | -2 | -9 | -7 |
| Common Stock Issued | 76,251 | 3,695 | 3,392 | 82,598 | 40 |
| Other Financing Activity | -355 | 0 | 0 | -352 | 0 |
| Financing Cash Flow | $75,847 | $3,691 | $3,390 | $82,237 | $33 |
| Exchange Rate Effect | N/A | 3 | -11 | 10 | 9 |
| Beginning Cash Position | 143,093 | 143,093 | 143,093 | 76,928 | 76,928 |
| End Cash Position | 202,028 | 130,474 | 139,925 | 143,093 | 66,306 |
| Net Cash Flow | $58,935 | $-12,619 | $-3,168 | $66,165 | $-10,622 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,346 | -15,234 | -6,440 | -15,394 | -10,758 |
| Capital Expenditure | -1,566 | -1,079 | -107 | -879 | -97 |
| Free Cash Flow | -16,912 | -16,313 | -6,547 | -16,273 | -10,855 |